Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-10

Clinical Trial Update: RELAXaHEAD for Headache Patients (Phase III) [NA]

View source ↗

Summary

Ongoing Phase III clinical trial RELAXaHEAD for migraine at NYU Langone Health, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Migraine | NA | Status: RECRUITING